4//SEC Filing
Boylan James P 4
Accession 0001415889-24-017526
CIK 0001472012other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:01 PM ET
Size
5.9 KB
Accession
0001415889-24-017526
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Boylan James P
Director
Transactions
- Award
Stock option (right to buy)
2024-06-13+11,333→ 11,333 totalExercise: $16.04Exp: 2034-06-12→ Common Stock (11,333 underlying)
Footnotes (2)
- [F1]Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities.
- [F2]The options vest in 4 quarterly installments, commencing from June 13, 2024 until the one year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001953094
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 9:01 PM ET
- Size
- 5.9 KB